Carroll Financial Associates, Inc. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 247 filers reported holding HAEMONETICS CORP in Q4 2017. The put-call ratio across all filers is 1.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
Carroll Financial Associates, Inc. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2021$2,000
+100.0%
19
+18.8%
0.00%
Q4 2020$1,0000.0%160.0%0.00%
Q3 2020$1,000
-90.0%
16
-82.6%
0.00%
-100.0%
Q3 2018$10,000
+11.1%
92
-14.0%
0.00%0.0%
Q2 2018$9,000
+28.6%
1070.0%0.00%0.0%
Q1 2018$7,000
+600.0%
107
+328.0%
0.00%
Q4 2017$1,0000.0%250.0%0.00%
Q3 2017$1,000250.0%0.00%
Q2 2017$0250.00%
Other shareholders
HAEMONETICS CORP shareholders Q4 2017
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders